|
gptkbp:instanceOf
|
gptkb:brand
gptkb:drug
|
|
gptkbp:activeIngredient
|
gptkb:vardenafil
|
|
gptkbp:approvalYear
|
2003
|
|
gptkbp:approvedBy
|
gptkb:European_Medicines_Agency
gptkb:U.S._Food_and_Drug_Administration
|
|
gptkbp:ATCCode
|
gptkb:G04BE09
|
|
gptkbp:chemicalFormula
|
C23H32N6O4S
|
|
gptkbp:contraindication
|
nitrate medications
recent heart attack
recent stroke
severe liver impairment
|
|
gptkbp:drugClass
|
PDE5 inhibitor
|
|
gptkbp:form
|
10 mg
20 mg
5 mg
|
|
gptkbp:genericAvailable
|
yes
|
|
gptkbp:halfLife
|
4-5 hours
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Levitra
|
|
gptkbp:legalStatus
|
prescription only
|
|
gptkbp:manufacturer
|
gptkb:Bayer
gptkb:Schering-Plough
GlaxoSmithKline
|
|
gptkbp:marketedIn
|
gptkb:European_Union
gptkb:United_States
|
|
gptkbp:mechanismOfAction
|
inhibits phosphodiesterase type 5 (PDE5)
|
|
gptkbp:pregnancyCategory
|
Not for use in women
|
|
gptkbp:prescribes
|
adult men
|
|
gptkbp:prescriptionRequired
|
yes
|
|
gptkbp:routeOfAdministration
|
oral
|
|
gptkbp:sideEffect
|
dizziness
headache
nasal congestion
dyspepsia
flushing
|
|
gptkbp:storage
|
room temperature
|
|
gptkbp:usedFor
|
erectile dysfunction
|
|
gptkbp:bfsParent
|
gptkb:Bayer
|
|
gptkbp:bfsLayer
|
5
|